CCHD Screening Saves Lives


Eve Newborn Screening Application*
for the Radical-7® Pulse CO-Oximeter®

Eve Newborn Screening Application* combines clinically proven Masimo Signal Extraction Technology (SET®) pulse oximetry with device-guided instruction designed to improve screening accuracy and efficiency

Newborn screening with Masimo SET® pulse oximetry has been shown to help clinicians increase critical congenital heart disease (CCHD) detection in three large studies of 181, 222 babies.1-3

Masimo SET® pulse oximetry measures through motion and low perfusion that cause other pulse oximetry technologies to drop out, falsely alarm, or miss true alarms.4

Hospitals implementing newborn screening may still experience challenges such as longer-than-necessary monitoring times, sensor misapplications, calculation errors, and confusion interpreting results.5

  1. Granelli AD, et al. BMJ 2009; 338: A3037.
  2. Ewer A, et al. Health Technol Assess. 2012;16(2):1-184.
  3. Zhao Q-m, et al. The Lancet, Early Online Publication, 23 April 2014. doi:10.1016/S0140-6736(14)60198-7.
  4. Barker S.J. Anesth Analg. 2002 Oct;95(4):967-72.
  5. Oster M, et al. The Journal of Pediatrics. doi:10.1016/j.jpeds.2013.08.044.

* Referred to as “CCHD Mode” in Radical-7



Ewer Pulse Oximetry Screening for Congenital Heart Defects in Newborn Infants Granelli Impact of Pulse Oximentry Screening on the Detection of Duct Dependent Congenital Heart Disease
Kemper Strategies for Implementing Screening for CCHD Pediatrics Sales Tool CCHD Screening Adhesive Sensor
Qu-ming Zhao Pulse oximetry with clinical assessment to screen for congenital heart disease in neonates in China: a prospective study    

Eve Screen on the Radical-7

For Newborn Screening—Get SET with the Eve Newborn Screening Application*

Request More Information

* required